Evidence map›Paper›PMID 31231046›Full record

ArticleCell host & microbe2019

A Stem-Cell-Derived Platform Enables Complete Cryptosporidium Development In Vitro and Genetic Tractability.

Georgia Wilke, Lisa J Funkhouser-Jones, Yi Wang, Soumya Ravindran, Qiuling Wang, Wandy L Beatty, Megan T Baldridge, Kelli L VanDussen, Bang Shen, Mark S Kuhlenschmidt and 4 more

Abstract read
In one paragraph

Article in Cell host & microbe, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Novel organoids andParasitology · 2025
    Review
  15. Organoid-basedMicrobiology spectrum · 2025
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Georgia WilkeDepartment of Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63130, USA.
Lisa J Funkhouser-JonesDepartment of Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63130, USA.
Yi WangDepartment of Pathology and Immunology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63130, USA.
Soumya RavindranDepartment of Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63130, USA.
Qiuling WangDepartment of Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63130, USA.
Wandy L BeattyDepartment of Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63130, USA.
Megan T BaldridgeDepartment of Medicine, Division of Infectious Diseases, Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63130, USA.
Kelli L VanDussenDepartment of Pathology and Immunology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63130, USA.
Bang ShenDepartment of Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63130, USA.
Mark S KuhlenschmidtDepartment of Pathobiology, University of Illinois College of Veterinary Medicine, Urbana, IL 61802, USA.
Theresa B KuhlenschmidtDepartment of Pathobiology, University of Illinois College of Veterinary Medicine, Urbana, IL 61802, USA.
William H WitolaDepartment of Pathobiology, University of Illinois College of Veterinary Medicine, Urbana, IL 61802, USA.
Thaddeus S StappenbeckDepartment of Pathology and Immunology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63130, USA.
L David SibleyDepartment of Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO 63130, USA. Electronic address: sibley@wustl.edu.

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Infectious Diseases/Basic Microbial Pathogenic MechanismsT32AI007172 · NIAID · WASHINGTON UNIVERSITY · PI Daniel E. Goldberg, JENNIFER A PHILIPS · 1985 to 2026
$13.0M
DEFINING THE BASIS OF EPITHELIAL DEFECTS IN CROHN'S DISEASE PATIENTSK01DK109081 · NIDDK · WASHINGTON UNIVERSITY · PI VANDUSSEN, KELLI LYNN · 2016 to 2020
$737k
NIAID NIH HHS T32 AI007172NIDDK NIH HHS K01 DK109081NIDDK NIH HHS P30 DK052574
6 · The paper itself

Abstract

Despite being a frequent cause of severe diarrheal disease in infants and an opportunistic infection in immunocompromised patients, Cryptosporidium research has lagged due to a lack of facile experimental methods. Here, we describe a platform for complete life cycle development and long-term growth of C. parvum in vitro using "air-liquid interface" (ALI) cultures derived from intestinal epithelial stem cells. Transcriptomic profiling revealed that differentiating epithelial cells grown under ALI conditions undergo profound changes in metabolism and development that enable completion of the parasite life cycle in vitro. ALI cultures support parasite expansion > 100-fold and generate viable oocysts that are transmissible in vitro and to mice, causing infection and animal death. Transgenic parasite lines created using CRISPR/Cas9 were used to complete a genetic cross in vitro, demonstrating Mendelian segregation of chromosomes during meiosis. ALI culture provides an accessible model that will enable innovative studies into Cryptosporidium biology and host interactions.

Indexed as

Host-Pathogen InteractionsModels, TheoreticalAnimalsCells, CulturedCryptosporidiosisCryptosporidiumEpithelial CellsGenetics, MicrobialMice, Inbred C57BLMicrobiological Techniquesdevelopmenthost-pathogen interactionsmeiosisMendelian geneticsorganoidspathway analysisstem cellstranscriptomics

Identifiers

PMID31231046
PMCPMC6617391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.